Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Labauge

Showing results (1-10 of 142) with videos related to

Pageof 15
Sort By:
Revue Neurologique|November 6, 2017
Should we broaden indications for anti-JCV antibody tests in multiple sclerosis patients? NoP Labauge
Revue Neurologique|April 27, 2020
Do disease-modifying drugs (DMD) have a positive impact on the occurrence of secondary progressive multiple sclerosis? NoP Labauge
La Revue Du Praticien|August 16, 2001
[Inflammatory pathology of the spinal cord]P Labauge
Neuro-Chirurgie|May 15, 2007
[Familial forms of central nervous system cavernomas: from recognition to gene therapy]P Labauge
International MS Journal|August 13, 2009
Magnetic resonance findings in leucodystrophies and MSP Labauge
Presse Medicale (Paris, France : 1983)|January 18, 1997
[Postural or orthostatic tremor: a variant of static tremor]P Labauge, L Coeroli
Revue Neurologique|April 14, 2009
[Social handicap at the onset of the multiple sclerosis]A Créange, P Labauge
Acta Neurologica Belgica|December 1, 2010
Macroglossia in adult Duchenne muscular dystrophyD Renard, V Humbertclaude, P Labauge
Revue Neurologique|January 1, 1991
[Neurologic complications of essential thrombocythemia. 6 cases]R Labauge, M Pagès, P Labauge
Revue Neurologique|April 22, 2020
Diagnostic and therapeutic issues of inflammatory diseases of the elderlyX Ayrignac, C Carra-Dallière, P Labauge
Pageof 15

Showing results (1-10 of 142) with videos related to

Sort By:
Pageof 15
Revue Neurologique|November 6, 2017
Should we broaden indications for anti-JCV antibody tests in multiple sclerosis patients? NoP Labauge
Revue Neurologique|April 27, 2020
Do disease-modifying drugs (DMD) have a positive impact on the occurrence of secondary progressive multiple sclerosis? NoP Labauge
La Revue Du Praticien|August 16, 2001
[Inflammatory pathology of the spinal cord]P Labauge
Neuro-Chirurgie|May 15, 2007
[Familial forms of central nervous system cavernomas: from recognition to gene therapy]P Labauge
International MS Journal|August 13, 2009
Magnetic resonance findings in leucodystrophies and MSP Labauge
Presse Medicale (Paris, France : 1983)|January 18, 1997
[Postural or orthostatic tremor: a variant of static tremor]P Labauge, L Coeroli
Revue Neurologique|April 14, 2009
[Social handicap at the onset of the multiple sclerosis]A Créange, P Labauge
Acta Neurologica Belgica|December 1, 2010
Macroglossia in adult Duchenne muscular dystrophyD Renard, V Humbertclaude, P Labauge
Revue Neurologique|January 1, 1991
[Neurologic complications of essential thrombocythemia. 6 cases]R Labauge, M Pagès, P Labauge
Revue Neurologique|April 22, 2020
Diagnostic and therapeutic issues of inflammatory diseases of the elderlyX Ayrignac, C Carra-Dallière, P Labauge
Pageof 15